CSL has been clear it does not intend to make its own COVID-19 vaccine at this stage, but the company says it’s pursuing new science to ensure its flu vaccine products keep up with the competition.
source https://www.smh.com.au/business/companies/competitive-advantage-new-flu-vaccine-research-a-focus-for-csl-20210903-p58olc.html?ref=rss&utm_medium=rss&utm_source=rss_feed
source https://www.smh.com.au/business/companies/competitive-advantage-new-flu-vaccine-research-a-focus-for-csl-20210903-p58olc.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Tags:
Sydney Morning